APOB and metabolic dysfunction-associated steatotic liver disease: Compared to the A subtype, patients with NAFLD with subtype C exhibited hypertriglyceridemia, elevated VLDL-TG, VLDL-Apo-B, increased small and dense LDL particles (LDL5 and LDL6), and remnant lipoprotein cholesterol (the sum of cholesterol associated with VLDL an IDL).